dianabol

 

Dianabol®  history – use and dosages

Most articles about steroids start with the use of Dianabol at the end of the 1950’s or 1960 in  bodybuilding. Most of these articles also claim that Dr Ziegler  (on the picture on the left) alone or in concert with CIBA, developed 1-dehydro-17α -methyl-testosterone methandrostenolone Dianabol®  Let us review the facts briefly and see what it learns us.

But..Dr.John Ziegler was not the inventor of Dianabol  You can find it anywhere on the web, if you search for information about the history of Dianabol or methandrostenolone. That one sentence. "Methandrostenolone was originally developed by John Ziegler and released in the U.S. in 1956 by Ciba."  It is even in the lemma about Dianabol in Wikipedia.

An article states : “Ziegler discovered a kinder  gentler testosterone, according to sources, he submitted his discovery to the Ciba Pharmaceutical company and they agreed to purchase the formula. He was paid $100."

A nice story, but it is not true. Ziegler had nothing to do with the invention of dianabol. Ziegler was a doctor, not a chemist. You can follow the development of Dianabol in the patent literature of the fifties. In these patentapplications you will never find the name of John Bosley Ziegler. What John Ziegler did was researching the effects of these new means “in vivo” on the York weightlifters.

 

The Godfather of Dianabol

Once upon a time, elite athletes who took extreme doses of anabolic steroids were sure that the drugs helped them jump higher, run faster, grow stronger. But these notions had never been verified in a lab. So in 1975 a British physiology professor at the University of Leeds, G. Romaine Hervey, set up an experiment to determine whether high doses of steroids truly boosted athletic performance or just gave users a psychological edge. "We knew young men who lifted weights felt that anabolic steroids helped them lift more, but we really didn't know [if they did]," says Hervey, now 83. "And since steroids did seem to make them bigger, we wanted to see whether that was normal muscle or water or something else."

It was a worthy inquiry, but Hervey was undone by one monumental oversight: He allowed 25-year-old Tony Fitton to observe the study. An industrial chemist and a top British powerlifter, Fitton watched with delight as the 11 subjects, gathered in a hotel room near campus, received boxes of the anabolic steroid Dianabol -- a drug he had been regularly using for three years. The instant Hervey left the room, Fitton took over. "Lads, the dosages are a bit high," he said of Hervey's regimen of 20 five-milligram tablets a day for six weeks. "If you feel more inclined to taking just two tablets a day, I'll buy [the rest] off you." As Fitton recalls, almost everyone in the room accepted his offer. Naturally, the subjects did not show appreciable strength gains at the end of the study. Fitton, meanwhile, had procured a cache of Dbol that he could deal or dole out to his lifting buddies.